Skip to content

VitaNova Life Sciences Corporation

VNOV

CIK 0001699709

← back to feed
Revenue (TTM)
$1.55M
+366.5% YoY Q3 Mar 2026
Net Income (TTM)
$18.13K
+503.9% YoY Q3 Mar 2026
EPS Diluted (TTM)
$0.00
+200.0% YoY Q3 Mar 2026
Gross Margin
53.9%
Q3 Mar 2026
Operating Margin
14.4%
Q3 Mar 2026
Net Margin
1.2%
Q3 Mar 2026
Free Cash Flow (TTM)
—
Q3 Mar 2026
Cash
$808.36K
Q3 Mar 2026
Total Debt
—
Q3 Mar 2026
Shares Outstanding
8.34M sh
Q3 Mar 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings